Findings of Australian Trial of CSL’s Pandemic H1N1 2009 Swine’
Limited, Australia’s heading biopharmaceutical company, voiced a Journal of a American Medical Association has published interpretation from a clinical hearing conducted in Australia to investigate CSL’s pandemic H1N1 2009 swine’ flu vaccine.






